Digestive Care, Inc.
Building Confidence in Pancreatic Care

For people living with exocrine pancreatic insufficiency (EPI), managing daily life often involves more than taking medication. Understanding nutrition, timing enzyme replacement therapy correctly, and maintaining access to treatment can all play an important role in achieving better outcomes.

Digestive Care, Inc. (DCI), has built its services around addressing these challenges and supporting both patients and healthcare providers throughout the treatment journey.

With a focus on pancreatic enzyme replacement therapy (PERT), DCI works in a specialized area of healthcare where education and personalized support are essential. PERT is designed for individuals who do not produce enough pancreatic enzymes to properly digest food and absorb nutrients. The therapy is used in patients with conditions such as cystic fibrosis and other diseases associated with pancreatic insufficiency.

Rather than limiting its role to providing a prescription product, DCI works with patients to help them understand their condition and the role enzymes play in their everyday health.

Beyond the Prescription

One of the ways DCI differentiates itself is through the support services it provides. The company works closely with healthcare professionals, including gastroenterologists, cystic fibrosis specialists, and other providers who treat patients with pancreatic conditions.

A major part of this effort involves nutrition education. Because every patient’s needs are different, understanding how diet, symptoms, and enzyme use connect is an important part of managing EPI. Through support programs, eligible patients can connect with registered dietitians who provide guidance based on their individual situations.

Steve Berens, Executive Vice President of DCI, believes this additional layer of support helps address a gap many patients face. “We help the physician out by offering this service for their patients so that they can access nutrition guidance that they normally would not have available,” he explains.

This approach reflects DCI’s belief that effective treatment requires more than simply providing medication. Patients often need reliable information and ongoing guidance to feel confident managing a complex condition.

Improving Access to Care

Along with education, DCI places significant attention on helping patients access the therapy they need. Navigating insurance requirements, affordability concerns, and pharmacy coordination can be challenging for many families. Through patient assistance and support programs, the company works to make the process easier for eligible patients.

The company’s efforts are especially important because EPI can affect individuals differently. Treatment decisions may depend on factors such as symptoms, nutritional needs, and the severity of pancreatic enzyme deficiency. By providing resources that complement physician care, DCI helps patients and providers make more informed decisions.

Focusing on Specialized Healthcare Needs

Operating in a highly specialized therapeutic area has shaped DCI’s approach. The company’s experience in pancreatic care allows it to focus deeply on the needs of patients who require enzyme replacement therapy.

As awareness of EPI continues to grow, DCI remains focused on improving conversations between patients and healthcare providers. The company continues to invest in educational resources designed to increase understanding of pancreatic insufficiency and the role of enzyme therapy.

For DCI, the goal is not only to provide a treatment option but also to support the people who rely on it. By combining pharmaceutical expertise with patient education and access programs, the company continues to build a more comprehensive approach to pancreatic care.

In a field where treatment can require careful adjustment and ongoing learning, DCI’s commitment lies in helping patients and providers navigate the challenges of EPI with greater knowledge, support, and confidence.